Skip to content

Importance of Molecular Diagnostic tests in Spinal Infections

Role of Molecular Diagnostics in Spinal Infections

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028218
Enrollment
94
Registered
2020-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M01X- Direct infection of joint in infectious and parasitic diseases classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Harshit Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients admitted to KMC Manipal in Orthopaedics department with spinal infections for whom molecular diagnostics, biopsy , histopathology and differential counts were done. 2)Patients who have following spinal infections- 1)TB spine 2)Staphylococcal infection 3)Brucella infection 4)Streptococcal infection 5)Burkholderia infection 6)E.coli infection

Exclusion criteria

Exclusion criteria: 1)Patients who did not undergo molecular imaging/diagnostic tests for diagnosis of spinal infections. 2)Patients those were already partially treated elsewhere for spinal infections on time of presentation.

Design outcomes

Primary

MeasureTime frame
detective capabilities(senstivity) of molecular diagnostics in spinal infections and its correlation with conventional methods such as blood culture and histopathology .Timepoint: 2 years

Secondary

MeasureTime frame
resistance pattern and response to treatment to antibiotics of these infections using clinical and radiological assessment tools.Timepoint: 2 years

Countries

India

Contacts

Public ContactDr Shyamasunder Bhat

KMC Manipal

shyambhat.n@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026